PET imaging of amyloid deposition in patients with mild cognitive impairment |
| |
Authors: | Forsberg Anton Engler Henry Almkvist Ove Blomquist Gunnar Hagman Göran Wall Anders Ringheim Anna Långström Bengt Nordberg Agneta |
| |
Affiliation: | Anton Forsberg, Henry Engler, Ove Almkvist, Gunnar Blomquist, Göran Hagman, Anders Wall, Anna Ringheim, Bengt Långström,Agneta Nordberg, |
| |
Abstract: | It is of great clinical value to identify subjects at a high risk of developing AD. We previously found that the amyloid positron emission tomography (PET) tracer PIB showed a robust difference in retention in the brain between AD patients and healthy controls (HC). Twenty-one patients diagnosed with MCI (mean age 63.3 ± 7.8 (S.D.) years) underwent PET studies with 11C-PIB, and 18F-fluoro-deoxy-glucose (FDG) to measure cerebral glucose metabolism, as well as assessment of cognitive function and CSF sampling. Reference group data from 27 AD patients and 6 healthy controls, respectively, were used for comparison. The mean cortical PIB retention for the MCI patients was intermediate compared to HC and AD. Seven MCI patients that later at clinical follow-up converted to AD (8.1 ± 6.0 (S.D.) months) showed significant higher PIB retention compared to non-converting MCI patients and HC, respectively (ps < 0.01). The PIB retention in MCI converters was comparable to AD patients (p > 0.01). Correlations were observed in the MCI patients between PIB retention and CSF Aβ1-42, total Tau and episodic memory, respectively. |
| |
Keywords: | Mild cognitive impairment Converters Amyloid PET PIB FDG CSF biomarkers |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|